Syneos Health, a biopharmaceutical solutions organization, agreed to acquire StudyKIK, a technology-enabled clinical trial recruitment and retention company. Financial terms are not disclosed. “StudyKIK’s patient-first focus, combined with their innovative enterprise platform, helps to advance our goal of bringing best-of-breed insights and technology-enabled solutions to biopharma customers, sites and patients. We are excited to welcome the StudyKIK team to the Syneos Health family. Together we’ll accelerate product development by improving stakeholder experiences, realizing efficiencies in patient recruitment, engagement, improved access and diversity,” Alistair Macdonald, Syneos Health CEO.